Company / Free Cash Flow per Share
Ginkgo Bioworks Holdings, Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$3.29
FY2025
5-year range
-$7.64 / -$0.18
FY2021-FY2025
Trend
+57.0%
vs FY2024
Sector context
#154 of 190
Health Care
What the data says
Ginkgo Bioworks Holdings, Inc.'s free cash flow per share of $-3.29 is lower than 81% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 7 years, ranging from $-7.64 in FY2024 to $-0.06 in FY2019.
Based on SEC 10-K filings.
-3.29 in FY2025.
Declined from $-0.18 to $-3.29 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 190This company -$3.29 Sector average $3.32
▼
-198.9% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 57.0% year-over-year.
- Ranks #154 out of 190 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2019.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.29 | +57.0% |
| FY2024 | -$7.64 | -4196.7% |
| FY2023 | -$0.18 | +5.9% |
| FY2022 | -$0.19 | +21.5% |
| FY2021 | -$0.24 | -58.5% |
| FY2020 | -$0.15 | -161.0% |
| FY2019 | -$0.06 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026